Sign In

Login

Password

Forgot Password ? Sign Up

فرط حمضات محرض باللمفاويات اللانموذجية (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "فرط حمضات محرض باللمفاويات اللانموذجية" in Arabic language version.

refsWebsite
Global rank Arabic rank
9nih.gov
4th place
6th place
7doi.org
2nd place
5th place
2semanticscholar.org
11th place
86th place

doi.org

  • Gotlib J (2015). "World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management". American Journal of Hematology. ج. 90 ع. 11: 1077–89. DOI:10.1002/ajh.24196. PMID:26486351. S2CID:42668440.
  • Roufosse F، Cogan E، Goldman M (2004). "Recent advances in pathogenesis and management of hypereosinophilic syndromes". Allergy. ج. 59 ع. 7: 673–89. DOI:10.1111/j.1398-9995.2004.00465.x. PMID:15180753. S2CID:23451016.
  • Boyer DF (2016). "Blood and Bone Marrow Evaluation for Eosinophilia". Archives of Pathology & Laboratory Medicine. ج. 140 ع. 10: 1060–7. DOI:10.5858/arpa.2016-0223-RA. PMID:27684977.
  • Carruthers MN، Park S، Slack GW، Dalal BI، Skinnider BF، Schaeffer DF، Dutz JP، Law JK، Donnellan F، Marquez V، Seidman M، Wong PC، Mattman A، Chen LY (2017). "IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series". European Journal of Haematology. ج. 98 ع. 4: 378–387. DOI:10.1111/ejh.12842. PMID:28005278.
  • Lefèvre G، Copin MC، Staumont-Sallé D، Avenel-Audran M، Aubert H، Taieb A، Salles G، Maisonneuve H، Ghomari K، Ackerman F، Legrand F، Baruchel A، Launay D، Terriou L، Leclech C، Khouatra C، Morati-Hafsaoui C، Labalette M، Borie R، Cotton F، Gouellec NL، Morschhauser F، Trauet J، Roche-Lestienne C، Capron M، Hatron PY، Prin L، Kahn JE (2014). "The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype". Medicine. ج. 93 ع. 17: 255–66. DOI:10.1097/MD.0000000000000088. PMC:4602413. PMID:25398061.
  • Roufosse F (2013). "L4. Eosinophils: how they contribute to endothelial damage and dysfunction". Presse Médicale. ج. 42 ع. 4 Pt 2: 503–7. DOI:10.1016/j.lpm.2013.01.005. PMID:23453213.
  • Curtis C، Ogbogu PU (2015). "Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia". Immunology and Allergy Clinics of North America. ج. 35 ع. 3: 387–402. DOI:10.1016/j.iac.2015.04.001. PMID:26209891.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Gotlib J (2015). "World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management". American Journal of Hematology. ج. 90 ع. 11: 1077–89. DOI:10.1002/ajh.24196. PMID:26486351. S2CID:42668440.
  • Roufosse F، Cogan E، Goldman M (2004). "Recent advances in pathogenesis and management of hypereosinophilic syndromes". Allergy. ج. 59 ع. 7: 673–89. DOI:10.1111/j.1398-9995.2004.00465.x. PMID:15180753. S2CID:23451016.
  • Boyer DF (2016). "Blood and Bone Marrow Evaluation for Eosinophilia". Archives of Pathology & Laboratory Medicine. ج. 140 ع. 10: 1060–7. DOI:10.5858/arpa.2016-0223-RA. PMID:27684977.
  • Carruthers MN، Park S، Slack GW، Dalal BI، Skinnider BF، Schaeffer DF، Dutz JP، Law JK، Donnellan F، Marquez V، Seidman M، Wong PC، Mattman A، Chen LY (2017). "IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series". European Journal of Haematology. ج. 98 ع. 4: 378–387. DOI:10.1111/ejh.12842. PMID:28005278.
  • Lefèvre G، Copin MC، Staumont-Sallé D، Avenel-Audran M، Aubert H، Taieb A، Salles G، Maisonneuve H، Ghomari K، Ackerman F، Legrand F، Baruchel A، Launay D، Terriou L، Leclech C، Khouatra C، Morati-Hafsaoui C، Labalette M، Borie R، Cotton F، Gouellec NL، Morschhauser F، Trauet J، Roche-Lestienne C، Capron M، Hatron PY، Prin L، Kahn JE (2014). "The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype". Medicine. ج. 93 ع. 17: 255–66. DOI:10.1097/MD.0000000000000088. PMC:4602413. PMID:25398061.
  • Roufosse F (2013). "L4. Eosinophils: how they contribute to endothelial damage and dysfunction". Presse Médicale. ج. 42 ع. 4 Pt 2: 503–7. DOI:10.1016/j.lpm.2013.01.005. PMID:23453213.
  • Schrezenmeier H، Thomé SD، Tewald F، Fleischer B، Raghavachar A (1993). "Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome". Experimental Hematology. ج. 21 ع. 2: 358–65. PMID:8425573.
  • Curtis C، Ogbogu PU (2015). "Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia". Immunology and Allergy Clinics of North America. ج. 35 ع. 3: 387–402. DOI:10.1016/j.iac.2015.04.001. PMID:26209891.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Gotlib J (2015). "World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management". American Journal of Hematology. ج. 90 ع. 11: 1077–89. DOI:10.1002/ajh.24196. PMID:26486351. S2CID:42668440.
  • Roufosse F، Cogan E، Goldman M (2004). "Recent advances in pathogenesis and management of hypereosinophilic syndromes". Allergy. ج. 59 ع. 7: 673–89. DOI:10.1111/j.1398-9995.2004.00465.x. PMID:15180753. S2CID:23451016.